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ABSTRACT
Background : Chest infection is the major
cause of morbidity and mortality among
patients with haematological malignancies.
Conventional  diagnostic methods – chest x-
ray , blood and sputum culture have limited
yield . We  used   fibreoptic bronchoscopy
and  bronchoalveolar lavage to evaluate
nature of pulmonary infiltrates on chest x-
ray.
Patients and Methods :
25 patients with  haematological
malignancies with fever and pulmonary
infiltrates  were studied.  Patients median
age was 32 years, ranging from 16 to 65
years. There were 21 males and 4 females.
Init ial  evaluation included – detailed
physical examination including chest to see
for any focus of infection.  In all  patients ,
base l ine blood counts (total and
differential), chest x-ray and  cultures  from
blood and other body fluids were taken
before starting broad spectrum antibiotics .
Those not responding over next 48-72 hours
received  gram positive coverage  followed by
amphotericin-B therapy .   Patients with
persistent fever and  pulmonary infiltrates
were subjected to fibre-optic bronchoscopy
(FOB) and bronchoalveolar lavage (BAL) and
samples were collected for bacterial, fungal,
AFB and viral studies.  The findings  were
correlated  with  Chest x-ray and CT scan.
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Results
The  median time  for FOB and BAL was 16
days (range, 3 to 32 days) after the clinical
diagnosis of chest infection..  BAL fluid
examination/culture grew microbial
isolates in 21 of 25 patients (84%). Of these-
bacteria alone were present in 10,  fungi
alone  in 1  and  polymicrobial  isolates
were seen  in 10 patients (40%).  Later
included-  a combination of  bacteria and
fungi - in 2 patients, bacteria and AFB - 6
and a combination of bacteria, AFB and
fungi were seen in 2 patients. BAL changed
the radiological diagnosis in 14 patients
(56% diagnostic uti l i ty).  Therapy was
modified according to BAL results in 6
patients (therapeutic uti l i ty of 24 %).
Concordance between radiological and BAL
findings were found only in 5 patients
(20%).  FOB procedure was tolerated well,
with mild and reversible complications
(throat pain, transient hypoxia,
tachycardia)  in some patients.
CONCLUSIONS
Infections are  the main  cause of
pulmonary infi ltrates in  patients with
haematological malignancies.  Bacterial ,
fungal and mycobacterium tubercular
organisms are the main  isolates.  Isolation
of  ESBL positive organisms and polymicro-
bial isolates suggest inclusion of
appropriate initial empirical antibiotics  in
these patients to prevent  development of
resistant  organisms. Higher frequency of
AFB isolates (32%) was  the surprising
finding and need to be confirmed in future
studies.
Original Article-II
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INTRODUCTION
Infections are the major cause of morbidity and
mortal i ty in pat ients with  haematological
malignancies.  Chest  is the common site of
infection1-2.  Pulmonary infi l trates,  seen on
radiological investigations, in these patients  are
generally considered  to be  of  infective etiology.
Less frequently,  non-infectious causes are also
found ei ther  alone or in combinat ion .   In
presence of  fever with pulmonary infiltrates,
such  pat ients are started on empir ical
antibiotics along with antifungals.  In  a number
of patients these infiltrates persists in spite of
treatment, and the etiology remains obscure.
This could be due to infect ions caused by
resistant organisms. Super added infections
with other organisms, react ivat ion of latent
infect ions, or non-infect ious causes l ike
pulmonary haemorrhage, congestive cardiac
failure and the disease itself, can also cause
pulmonary shadows in this setting.3
Since the range of etiologies is very wide
in such a clinical setting, empirical therapy may
not always be appropriate. Specific diagnosis
and institution of specific treatment promptly
would be very critical to reduce the mortality
and morbidity in these patients.
In order to obtain appropriate mater ial  for
diagnosis, fiber optic  bronchoscopy (FOB) with
broncho-alveolar lavage (BAL) has been found
useful in these patients.4-11
We have recently conducted a study using
FOB and BAL in patients with haematological
mal ignancies with persistent pulmonary
inf i l t rates  to  determine the spectrum of
microbial pathogens involved in the etiology and
to correlate cl inical ,  radiological and BAL
findings to  assess  i f  this would help in
optimizing our therapeutic strategy for these
patients.  This report describes the results.
PATIENTS  & METHODS
Between January 2001 and June  2002,  patients
with haematological malignancies admitted in
the medical oncology ward were studied.
Patients  characteristics are shown in table-1.
Eligibility criteria included – (i) patients with
cl inical and radiological evidence of
pneumonitis, not responding to empirical anti
microbial  treatment for minimum of 48 hours,
( i i )  ECOG performance status ≤  2,  ( i i i )
hemodynamical ly stable. ( i .e.  normal blood
pressure, pulse rate and oxygen saturation)  (iv)
no evidence of   bleeding  diathesis,  (v)
supported platelet counts ≥ 100 x 109/L.
Pulmonary inf i l t rate  was def ined as
evidence of  pneumonitic  opacities  (pulmonary
infiltrates) seen  on Chest X Ray.  Fever  was
defined as single reading of oral temp ≥ 1010 F
or 2 values >  100.40 F recorded at least 1 hour
apart, unrelated to blood product transfusions or
chemotherapy drugs administrat ion. For
present study patients were defined to have
neutropenia  if absolute neutrophil count (ANC)
was ≤ 2.0 x 109/ L.
Initial evaluation for  a  febrile episode
included-  detailed  physical examination  for
any clinical focus of infection in chest or other
sites.  Complete haemogram  including absolute
neutrophil count  and aerobic blood cultures
from peripheral blood and central l ine were
taken. Chest x-ray was done to look for  any
pulmonary  infiltrate.  Wherever possible and
indicated , sputum  was submitted for direct
smear examination by gram stain, Ziehl- Nielson
(Z-N) stain for acid-fast baci l l i  (AFB) and
staining for demonstration of fungal hyphae.
Fiber opt ic bronchoscopy (FOB) and
bronchoalveolar lavage (BAL) - Each patient was
explained the nature of the procedure in detail
and an informed consent was taken. The patient
was kept on an overnight fast. A small dose of
sedative was given as pre -medication.
The FOB was introduced intranasally after
topical anaesthesia using lignocaine jelly. After
the bronchial  t ree was examined, the
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bronchoscope was wedged into the airway of the
involved lobe segment of the lung. 25-50 ml
aliquots of normal saline at room temperature
were instilled and gently aspirated using suction
machine into sterile trap bottles.12-13
BAL specimen was submitted for the  (i)
bacterial studies using Gram’s stain and aerobic
bacter ial  cul tures, both qual i tat ive and
quantitative. For quantitative cultures the BAL
fluid was diluted with normal saline from 1:102
to 1:104 t imes. It was then inoculated on to
culture media viz. blood agar, Mac Conkey’s agar
Table-1 Patients Characteristics
Total no of patients 25
Age median (range) 32 years (16-65)
Sex : M:F 21:4
Primary Diagnosis
A M L 10
N H L 5
CLL 3
HD 2
A L L 2
Myeloma 1
C M L 1
MDS 1
Presenting Symptoms/Signs
Fever 23
Cough 11
Haemoptysis 2
Chest Pain 3
Dyspnoea 2
Crepitations 10
Tachypnoea 1
Bronchial breath sounds 1
and chocolate blood agar. Thioglycollate broth
was also introduced if the results of culture
plates were negative. The colony count of > 104
cfu /ml was considered significant.  Studies for
acid-fast bacilli by Z-N stain and mycobacterial
cultures on Lowenstein- Jenson (LJ) medium.
(ii) Fungal studies by direct KOH mount and
fungal cul ture ( i i i )  Viral  studies for herpes
simplex virus (HSV) and cytomegalovirus
(CMV) by culture / PCR (iv) cytopathological
studies were done to look for malignant cells,
inflammatory cells, AFB, Pneumocystis carinii
by silver methanamine stain and hemosiderin.
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Table : 2 Radiological  Features
Sl No . CT Scan Findings X Ray Findings Radiological Impression
1 Not done Alveolar opacit ies Bacterial pneumonia
2 Alveolar opacit ies Alveolar opacit ies Bacterial pneumonia
3 Not done Alveolar opacit ies Bacterial pneumonia
4 Calcification, Nodular shadows Alveolar opacities Fungal Pneumonia
5 Not done Alveolar opacit ies Bacterial pneumonia
6 Alveolar opacities,
Calc i f icat ion Alveolar opacities Tuberculous Pneumonia
Lymph node enlargement
7 Alveolar opacit ies Alveolar opacit ies Bacterial pneumonia
8 Not done Alveolar opacit ies Bacterial pneumonia
9 Not done Nodular shadows Fungal Pneumonia
10 Not done Alveolar opacit ies
Pleural Effusion Bacterial Pneumonia
11 Not done Alveolar opacit ies Pleural Effusion
Bacterial Pneumonia
12 Alveolar opacities,  Lymph Alveolar opacit ies Bacterial Pneumonia
Node Enlargement.
13 Cavity, Alveolar opacities Cavity, Alveolar Tuberculous Pneumonia
14 Alveolar opacit ies Lymph
Node  Enlargement Alveolar opacities Tuberculous Pneumonia
15 N o r m a l Interstit ial Shadows Bacterial Pneumonia
16 Cavity/ Alveolar shadows Lymph Node Enlargement Bacterial Pneumonia
Lymph Node Enlargement
17 Cavity with fungal ball Cav i t y Fungal Pneumonia
18 Not done Alveolar Opacities Bacterial Pneumonia
19 Alveolar/  Nodular Alveolar opacit ies Bacterial Pneumonia
20 Alveolar Alveolar Bacterial Pneumonia
21 Not done Alveolar Opacities Bacterial Pneumonia
22 Alveolar/  Nodular Alveolar opacit ies Bacterial Pneumonia
23 Not done Alveolar/ Effusion Tuberculous Pneumonia
24 Interst i t ial  lesions Interst i t ial  opacit ies Tuberculous Pneumonia
25 Pleural Effusion/Alveolar Pleural Effusion/Alveolar Bacterial Pneumonia.
TREATMENT  PROTOCOL
All  pat ients  received broad spectrum
antibiot ics mainly third generat ion
cephalosporin plus amikacin  or a combination
of  piperacillin plus aminoglycosides.  Patients
were examined daily or twice a day for any focus
of infection.  At 48 to 72 hours, patients who
became afebri le  were cont inued on same
antibiot ics.  Patients who were st i l l  febri le,
antibiotics  were  changed  according to culture
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report .  Fo r  pa t i en t s  w i t h  evidence of
worsening, with culture sterile, amphotericin B
was added empir ical ly .  For pat ients with
central line,  gram positive cover was added
fol lowed by amphoteric in-B.  Pat ients with
persistent  pulmonary infiltrates despite above
antibiotics, were subjected to FOB and BAL.
The treatment was modif ied  based on the
results of BAL or  on clinical judgement where
BAL was negative. All the data was collected
according to pretested proforma and entered in
SPSS 10 software for statistical analysis.
RESULTS
Between January 2001 and June 2002, 25
patients with hematological malignancies were
included in the present  study.  The median age
was 32 years  ranging  from 16 to 65 years.  There
were 21 males and 4 females.  Underlying
haematological  diagnosis  was acute myeloid
leukemia ,n=10, non Hodgkin’s lymphoma ,n=5,
chronic lymphocyt ic leukemia (CLL)-3,
Hodgkin’s disease –2, and acute lymphoblastic
leukemia –2 and chronic myeloid leukemia
(CML) ,  mult iple myeloma (MM) ,   and
myelodysplastic syndrome  in one patient each.
Symptoms and signs at the t ime of febr i le
episode are given in table-1.  Present ing
symptoms were – fever –23 (92%), cough (11),
chest pain-3, hemoptysis -2, dyspnoea –1, and
expectoration -1. The common  signs  were
crepitations on chest auscultation (10 patients).
Bronchial breath sounds and tachypnoea were
seen in one patient each.  In 14 patients (56%),
no signs of pneumonitis could be detected.
RADIOLOGICAL FEATURES
Table –2 depicts the radiological features of the
patients. CT scan of chest was available in 16
patients. Chest radiographs was done for all the
pat ients. In 15 pat ients the radiological
diagnosis was bacterial  pneumonia. Fungal
pneumonia and tuberculous pneumonia was
suspected  in 5 patients each.
HAEMATOLOGICAL INVESTIGATIONS
Eight patients (32%) were non-neutropenic for
the ent ire durat ion of the episode of
pneumonit is whi le 17 pat ients (68%) had
neutropenia at some point during the episode.
On the day of BAL, 14 patients (56%) were
neutropenic (ANC< 2.0x109/L), while 11 patients
(40%) were non neutropenic . (grade 0, ANC >
2.0X109/L). 4 patients had grade 4 (ANC < 0.5X
109/L) neutropenia. Sputum f indings In 4
patients sputum culture grew bacteria, In one
patient - fungus candida albicans was isolated,
and in 1 patient the culture was sterile. In 15
patients no sputum sample was available while
in 4 pat ients the sample was found to be
inappropriate on microbiological examination.
Concordance between sputum and BAL was seen
only in one patient.
BRONCHO ALVEOLAR LAVAGE (BAL) FLUID
FINDINGS
The  median time  for FOB and BAL was 16 days
(range, 3 to 32 days) after the clinical diagnosis
of chest infect ion..  BAL f luid examinat ion/
culture grew microbial  isolates in 21 of 25
patients (84%). Overall bacterial isolates were
seen in 20 patients (80%), while fungi were
isolated in 5 patients (20%). In 8 patients (32%)
AFB was demonstrated.
Bacteria alone were found in 10 patients
whi le fungi alone were seen in 1 pat ient.
Polymicrobial  isolates  were seen  in 10 patients
(40%).  A combination of bacteria and fungi
were seen in 2 patients, while bacteria and AFB
were seen in 6 pat ients. A combinat ion of
bacteria, AFB and fungi were seen in 2 patients.
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Table-4 : Microbiological  Spectrum
Organisms isolated Number of patients
Pseudomonas aeruginosa
ESBL  + 9
ESBL   - 2
E. coli (ESBL -) 1
Acinetobacter (ESBL+) 1
Mixed Growth (bacteria) 7
Total no. of positive cases 20 ( 80%)
Fungi:
Organism N u m b e r
Candida tropicalis 1
Aspergi l lus fumigatus 3
Aspergillus niger + A. flavus 1
Tota l 5
Table-3 : Microbial Isolates
Total no of microbial isolates 21 84%
Type No %
Bacterial alone 10 40
Fungi alone 1 4
AFB alone 0 0
Bacteria + Fungi 2 8
Bacteria + AFB 6 24
Bacteria + AFB + Fungi 2 8
To ta l 21 84%
                         Table –5 :  Isolation of Acid Fast Bacilli (AFB) in BAL Fluid
Patient No AFB Smear AFB on A F B
Cytology Cu l tu re Comments
sample
4 + - -ve Improved on ATT
 (14 months follow up)
8 + + -ve Improved on ATT. LFU
(4 months)
10 + + + -ve Improved on ATT,LFU.
 (2 months)
13 + - -ve Died of GVHD
18 - + / - +ve Improved on ATT
19 - + + + -ve Improved on ATT.
Follow up (2months)
20 - + -ve Improved, No ATT
 (4 months follow up)
21 - + + -ve Improved, No ATT
Evidence of TB spine, 3
months follow up
ATT- Anti tuberculosis treatment, LFU- Lost to follow up, GVHD- Graft v/s host disease.
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BACTERIOLOGY
Bacteria were isolated in a total of 20 patients.
Extended spectrum β- lactamase producing
(ESBL+) pseudomonas aeruginosa was the
commonest species of bacter ia isolated (9
patients). Other bacteria isolated included ESBL
(-) Pseudomonas aeruginosa  in  2 patients, ESBL
(-) Esherichia coli in 1 patient and ESBL (+)
Acinetobacter in 1 patient.  In 7 patients a
polymicrobial  growth was grown on culture.
Fungi  were grown on culture in 5 patients.
Aspergillus fumigatus was grown in 3 patients.
In 1 pat ient a combinat ion of A.niger and
A.flavus was seen, while Candida tropicalis was
seen in 1 patient. None of the patients were
positive for the direct KOH stain.
Acid Fast Bacilli:  Eight out of 25 patients (32%)
had AFB isolated from the BAL specimen . In 4
patients AFB was  detected in the routine Z-N
stain.  Another 4 cases were detected to be AFB
positive when the same samples were processed
for cytopathology.  However only 1 pat ient
had a posit ive culture for mycobacter ium
tuberculosis.
Six pat ients were started in ant i
tuberculous treatment (ATT) based on the
results of BAL. Two patients were kept on follow
up without ATT, as their chest infiltrates had
cleared up completely with empirical antibiotic
and ant i fungals treatment.  On fol low up,
pulmonary infi ltrates in 7 patients improved.
One patient expired before response to ATT
could be assessed due to other co - morbid
conditions.
VIRUSES
Samples could be processed for viruses in 15
patients. Herpes simplex virus (HSV) was
identified in 1 patient by PCR. This patient had
undergone treatment with allogeneic peripheral
stem cell transplant for CML.
RADIOLOGICAL, CLINICAL AND BAL
CORRELATION
Table –6  shows the radiological and clinical
correlat ion with BAL f indings..  The f inal
respiratory diagnosis after the BAL results
were, bacterial pneumonia in 10 patients, fungal
pneumonia in 1 patient and mixed group of
infection in 10 patients. In 4 patients the BAL
cultures were sterile; two of these patients had
BAL f luid stain posit ive for hemosiderin,
suggestive of  pulmonary hemorrhage.  BAL
changed the radiological diagnosis in 14 patients
(56% diagnostic utility). Therapy was modified
according to BAL results in 6 pat ients
(therapeutic ut i l i ty of 24%). Concordance
between radiological and BAL findings were
found only in 5 patients (20%).
Complicat ions of BAL :  The procedure of
Bronchoscopy was well tolerated by the patients
and the problems encountered (tachycardia- 12
, hypoxia- 6  , throat pain-9 ) were mild and
reversible. One pat ient developed mild
epistaxis, which responded to conservat ive
management.
DISCUSSION
We carried out  present study to evaluate nature
of pulmonary infiltrates  using BAL and compare
with conventional method of diagnosis e.g.
clinical, radiology , blood and sputum culture .
Even though the no of  patients studied was
small,  the study population was unique as it
included pat ients of various haematological
mal ignancies both neutropenic and non
neutropenic.
Presence of fever in most neutropenic
patients is generally indicative of an underlying
infective cause. However, localizing signs may
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Table 6 : Clinical , radiological  and BAL Correlation with Final Outcome
Sl. Radiologic BAL BAL B A L Final
no Impression findings Changed Modi f ied Respiratory Final outcome
diagnosis treatment diagnosis
1 BP A.fumigatus. Yes No FP improved
2 BP P.aeruginosa+ No No BP improved
3 BP Steri le No No Idiopathic improved
4 FP P.aeruginosa+
AFB Yes Yes Mixed Infection improved
5 BP Steri le No No Idiopathic improved
6 TB P.aeruginosa+ Yes Yes BP improved
7 BP P. aeruginosa (-) No No BP improved
8 BP Poly microbial
A.flavus,A.niger
AFB Yes Yes Mixed Infection improved
9 FP Polymicrobial
A.fumigatus Yes No Mixed Infection improved
10 BP Poly microbial
AFB Yes No Mixed Infection improved
11 BP P.aeruginosa+
C. tropicalis Yes No Mixed Infection improved
12 BP Poly Bacterial
Hemosiderin No No BP
 Pulmon H’ge improved
13 TB Poly Bacterial
A.fumigatus AFB Yes Yes Mixed Infection Died
14 TB Steri le No No Idiopathic improved
15 BP P.aeruginosa+ No No B P Improved
Hemosiderin ? Pulmon H’ge
16  BP Acinetobacter (+) Yes Yes BP improved
Hemosiderin
17 FP Polymicrobial Yes No BP improved
18 BP Polymicrobial
AFB Yes Yes Mixed Infection improved
19 FP P.aeruginosa+
AFB Yes No Mixed Infection improved
20 BP P.aeruginosa+
AFB Yes No Mixed Infection improved
21 BP P.aeruginosa (–)
AFB Yes No Mixed Infection improved
22 FP Poly microbial No No BP improved
23 TB P.aeruginosa
(+) No No BP improved
24 TB Steri le No No Idiopathic improved
25 BP Poly microbial No No BP improved
BP-bacterial pneumonia, FP-fungal pneumonia, TB-tubercular, Pulmon.Hge- pulmonary haemorrhage
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be subtle or absent. Respiratory signs were
present in less than half of the patients in  the
present study,  indicat ing  that signs of
respiratory infection are blunted in many of
these patients, as their capacity to mount an
inf lammatory response is l imited. This
highlights the importance of other modes of
investigations like chest radiographs14 and CT
scans in detecting onset of pulmonary infections
in these patients.15-18  Our study  also confirms
earlier observations1-2 that sputum studies are
not appropriate for this group of pat ients.
Fifteen patients could not give a sample and in
4 patients the sample was inappropriate. This is
most probably due to the fact that these patients
do not mount a significant immune response, as
they are immunosuppressed.
Gram negative pathogens were the most
common isolates. In 10 out of 20 patients ESBL
positive bacteria were isolated. This points out
to the emergence of these types of organisms as
an important cause of infect ion in these
patients. This also highlights the importance of
using antibiotics that are capable of neutralizing
the β-lactamase, produced by these organisms
and incorporating them into upfront empirical
antibiotic combinations. Gram-positive bacteria
were not isolated separately in our study. This
is in contrast to the global trends where in gram-
positive bacteria are replacing gram-negative
bacteria as the predominant infecting agent in
these groups of patients.19 This may be partly
due to the fact that effective antibiotics active
against gram-positive bacteria are incorporated
early as part of empirical antibiotic therapy. It
is important to remember that infection patterns
vary considerably depending on local factors.
Therefore each inst i tut ion must have an
antibiotic policy based  on  local prevalence and
sensitivity patterns.
It is interesting to note that in a significant
proportion of the patients in whom microbes
were isolated (10 out of 21), more than one type
of organism (mixed infection) were present.
Mixed infections cannot be detected by the
routine clinical and radiological tests. In this
aspect, BAL forms an important diagnostic tool
for these patients to optimize antimicrobial
treatment.
In 7 out of 20 patients in whom bacteria
were isolated, multiple bacteria were grown
simultaneously. This may represent actual
infection with more than one bacterium or may
be due to contaminants. One of the disadvan-
tages of the FOB is the possible contamination
during i ts introduct ion through the nasal
passage. Therefore it is important to be careful
during the procedure of collection and transport
of the BAL specimen. Surveillance cultures from
the upper airways and correlation with the BAL
isolates may be helpful  in dist inguishing
between contamination from the upper airway
and true infect ion of the lower respiratory
tract.4  Quantitative estimation of the cultures
also would be helpful in this regard.
Fungi could be grown in culture from 5
patients. However none of the patients stained
posit ive for fungi from the direct KOH
examination. Two out of the 5 patients has
received Amphotericin - B as part of empirical
treatment, which might have been a reason for
KOH preparation being negative. Sensitivity of
the organism to antifungals drugs was not done
in our study.  One patient , who had evidence of
cavity with fungal ball inside, which was highly
suggest ive of Aspergi l losis radiological ly,
however did not show any fungal growth on BAL
culture. This pat ient also had received
empir ical  ant i fungals therapy with
Amphotericin-B, which might have been the
reason. This highl ights the fact that BAL
findings can be falsely negative as far as fungal
infections are concerned . Strong clinical or
radiological evidence of fungal infection should
be treated with full course of antifungal therapy,
as BAL cultures can be ster i le for fungi,
especially if the patient has already been started
on anti fungal therapy empirically.20
Eight out of 25 (32%) pat ients had
evidence of AFB. This was higher than
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expected. It is of interest to note that in all the
patients the AFB was seen either in combination
with bacteria (6 patients) or in combination
with fungi (2 patients).  However,  only one
sample out of the 8 positive for AFB grew on
culture. This may have been due to the fact that
most of the pat ients had received broad-
spectrum antibiotics (including amikacin) as
part of their empirical antibiotics, to which the
AFB may have been sensit ive. Species
determination of the AFB was not done in our
study. It should kept in mind that the pulmonary
infi ltrates cleared up in all the 7 patients in
whom response could be assessed. This was due
to the fact that AFB was seen in combination
with either bacteria or fungi and all the patients
received broad-spectrum antibiotics and anti-
fungals therapy for the same. Two patients were
not put on anti tubercular treatment (ATT) as
their pulmonary lesions completely cleared and
were kept under observation. Interestingly one
of them, subsequently developed clinical and
radiological evidence of spinal tuberculosis with
paraparesis after a period of  2 months and was
put on ATT.
The high incidence of AFB in our study
was unexpected but not surprising.  A study by
Modi et al21  from our institute using FOB and
BAL in post renal transplant patients, revealed
an incidence of 39 % (7 out of 18 cases). The high
prevalence of mycobacterium in our population
is well known.1-2 This could either represent a
reactivation of latent infection, which is more
l ikely,  or a new infect ion.22  Infect ion with
mycobacterium is many a time missed out in
these patients, as they usually have other acute
infections, which are more readily manifested.
However the possibi l i ty of underlying
mycobacterium infection must be always be
kept in mind whi le treat ing these pat ients.
Another issue that must be addressed in this
regard is the possibi l i ty of mycobacter ial
contamination of the bronchoscope.  We had
detected AFB once, during routine examination
of bronchoscope washing. This highlights proper
maintenance and decontaminat ion of the
instruments to avoid false positive results.
In our study only one instance of HSV
(out of 15 cases tested) was found. This was in
the patient who underwent transplant.  Probably
viral  infect ions are not a major cause of
morbidity in hematological malignancies and
are more important in patients undergoing bone
marrow transplant only.23 However our study
sample size was smal l  for any def ini t ive
conclusions in this regard.  Our study did not
reveal any Pneumocytstis carinii. The exact
reason for this was not very clear. 24
The median number of days between
onset of symptoms and BAL was 16 days. This
was more than that was anticipated. This was
due to the fact that most of our patients who
developed pneumonit is were having a poor
performance status (PS). Therefore we had to
delay procedure till the performance status of
the patients improved so that they could tolerate
the procedure. Also we had to ensure a platelet
count of at least 100x10 9 /L. This was difficult
to achieve as most of the patients had received
intensive cytotoxic therapy and subsequently
were severely myelosuppressed. Therefore in
achieving an adequate platelet count,  the
procedure was often delayed. A well-coordinated
approach and aggressive platelet support should
help in decreasing the time interval between
onset of symptoms and BAL.  Reduction of the
minimum required platelet count to 50 x 10 9/L,
in patients who does not have any evidence of
bleeding may be tr ied out in this regard.
Overall, the procedure was tolerated  well with
minor reversible complicat ions.  With
increasing experience and due precautions,
major complications seen in earlier days25-26 are
rarely encountered .
We had a diagnostic yield of 84 %. This
compares wel l  with the other studies
reported.4,10 However our therapeutic utility was
only 24 %. This could be due to the fact that
organisms in the pulmonary parenchyma take
more time to clear compared to blood.  BAL
would pick up these organisms, which were
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otherwise responding to the therapy.  Also our
empir ical  therapy protocol included agents
effect ive against ESBL + organisms. The
identification of organisms ensured that the full
courses of antimicrobial therapy could be given
to these patients as part of definitive therapy.
Therefore, the actual benefit to the patients may
have been higher than indicated. Furthermore,
if these organisms are not eradicated fully they
could form part of resistant colonization. These
could be potential source of further morbidity
in future chemotherapy courses. These finding
would probably help in optimizing empirical
ant imicrobial  therapy during future
chemotherapy schedules. Knowledge of
prevalence of organisms and their sensitivity
patterns would also help in formulating effective
empiric antibiotic protocols.19 This would help
in decreasing the morbidity and also in cutting
cost of antibiotic treatment.  Our finding also
emphasizes the importance of appropriate
empirical antimicrobial therapy, which forms
the mainstay of treatment for these patients.3
Our finding suggests that BAL has got
several potent ial  advantages in evaluat ing
patients with hematological mal ignancies.
However i t  must be emphasized that the
effectiveness of BAL depends on several local
factors. Presence of  good microbiological and
cytopathological back up is crucial in analyzing
the specimen. The availability of a dedicated
team to do the bronchoscopy is also very
important. A well-coordinated approach by all
the teams involved cannot be overemphasized.
In summary, our initial experience with
FOB and BAL in patients with hematological
mal ignancies pulmonary inf i l t rates is
encouraging. It has been a learning experience
and the results obtained would be of benefit in
planning further studies.
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